Home defeats leave Needham boss with win or bust approach for survival

Home defeats leave Needham boss with win or bust approach for survival

Needham cuts Sarepta stock target to $183, maintains buy By Investing.com

Needham cuts Sarepta stock target to $183, maintains buy By Investing.com

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference